Skip to main content

NeuroBo Pharmaceuticals, Inc. (NRBO)

NASDAQ: NRBO · Delayed Price · USD
1.86
-0.03 (-1.59%)
Pre-market:Oct 22, 2021 9:04 AM EDT
1.89
-0.02 (-1.05%)
At close: Oct 21, 4:00 PM
Market Cap50.52M
Revenue (ttm)n/a
Net Income (ttm)-29.81M
Shares Out22.20M
EPS (ttm)-1.55
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume266,799
Open1.91
Previous Close1.91
Day's Range1.88 - 1.94
52-Week Range1.82 - 7.61
Betan/a
AnalystsBuy
Price Target16.00 (+746.6%)
Est. Earnings DateNov 11, 2021

About NRBO

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an ac...

IndustryBiotechnology
Employees7
Stock ExchangeNASDAQ
Ticker SymbolNRBO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for NRBO stock is "Buy" and the 12-month stock price forecast is 16.00.

Price Target
$16.00
(746.56% upside)
Analyst Consensus: Buy

News

Best Penny Stocks to Buy Right Now? Here's 3 For Your Watchlist in October

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now?

Other symbols:DNNNSPR
1 week ago - PennyStocks

Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving Today

There's loads of hot penny stocks worth checking in on today and we're taking a look at what some of the top movers are doing! The post Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving To...

1 week ago - InvestorPlace

NeuroBo Pharmaceuticals Announces Positive Recommendation from Independent Data Safety Monitoring Committee of Phase ...

BOSTON, Oct. 13, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapie...

1 week ago - PRNewsWire

NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapie...

2 weeks ago - PRNewsWire

NeuroBo Pharmaceuticals Announces $14 Million Registered Direct Offering

BOSTON, Oct. 1, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapie...

3 weeks ago - PRNewsWire

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

Other symbols:AVIRHSTONVIVPRVBSYN
1 month ago - InvestorPlace

NeuroBo Pharmaceuticals Reports Second Quarter 2021 Financial Results

BOSTON, Aug. 16, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapie...

2 months ago - PRNewsWire

3 Biotech Penny Stocks That You Need to Know About In 2021

Are these the best biotech penny stocks to watch in 2021? The post 3 Biotech Penny Stocks That You Need to Know About In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...

Other symbols:NVIVSYN
3 months ago - PennyStocks

LCLP Stock: 10 Reasons Why Penny Stock Battery Maker Life Clips Is Plunging Today

Life Clips (LCLP) stock is falling on Tuesday following an update from the battery company about its recent business announcements. The post LCLP Stock: 10 Reasons Why Penny Stock Battery Maker Life Cli...

Other symbols:IMNM
3 months ago - InvestorPlace

Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the Move Today

Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details. The post Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the...

Other symbols:IMNMMRNANVAXOCGNQDEL
3 months ago - InvestorPlace

NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors Send Shares Rocketing

Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. The post NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors S...

3 months ago - InvestorPlace

NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors

BOSTON, July 12, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapie...

3 months ago - PRNewsWire

NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results

BOSTON, May 17, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies...

5 months ago - PRNewsWire

NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic Update

BOSTON, April 15, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapi...

6 months ago - PRNewsWire

2 Falling Knives to Catch

Wall Street recommends buying shares of NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) and Windtree Therapeutics Inc (NASDAQ:WINT), even though these two securities have shown poor performance over the prior...

Other symbols:WINT
6 months ago - GuruFocus

NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene

BOSTON, March 24, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has received approval of an amendment to its Continge...

6 months ago - PRNewsWire

NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement

BOSTON, Jan. 21, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the closing of its previously announced private placement of a...

9 months ago - PRNewsWire

NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program

BOSTON, Jan. 6, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that on December 31, 2020 it acquired ANA Therapeutics, a priva...

9 months ago - PRNewsWire

NeuroBo Pharmaceuticals (NRBO) Surges: Stock Moves 5.2% Higher

NeuroBo Pharmaceuticals (NRBO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results

BOSTON, Nov. 13, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapi...

11 months ago - PRNewsWire

NeuroBo Pharmaceuticals Reports Second Quarter 2020 Financial Results

BOSTON, Aug. 11, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc.

1 year ago - PRNewsWire

NeuroBo Pharmaceuticals to Join Russell 3000® and Microcap® Indexes

BOSTON, June 16, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapi...

1 year ago - PRNewsWire